SK284195B6 - Použitie prostanových derivátov a kombinácia týchto látok s antibiotikami na liečenie bakteriálnych infekcií - Google Patents

Použitie prostanových derivátov a kombinácia týchto látok s antibiotikami na liečenie bakteriálnych infekcií Download PDF

Info

Publication number
SK284195B6
SK284195B6 SK156-98A SK15698A SK284195B6 SK 284195 B6 SK284195 B6 SK 284195B6 SK 15698 A SK15698 A SK 15698A SK 284195 B6 SK284195 B6 SK 284195B6
Authority
SK
Slovakia
Prior art keywords
group
hydrogen atom
prostane derivatives
carbon atoms
treatment
Prior art date
Application number
SK156-98A
Other languages
English (en)
Slovak (sk)
Other versions
SK15698A3 (en
Inventor
Peter Scholz
J�Rg Weber
Klemens Angstwurm
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of SK15698A3 publication Critical patent/SK15698A3/sk
Publication of SK284195B6 publication Critical patent/SK284195B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A61K31/5585—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes having five-membered rings containing oxygen as the only ring hetero atom, e.g. prostacyclin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK156-98A 1995-08-11 1996-08-06 Použitie prostanových derivátov a kombinácia týchto látok s antibiotikami na liečenie bakteriálnych infekcií SK284195B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19530884A DE19530884C2 (de) 1995-08-11 1995-08-11 Verwendung von Prostan-Derivaten sowie deren Kombination mit Antibiotika zur Behandlung von bakteriellen Meningitis
PCT/EP1996/003481 WO1997006806A1 (en) 1995-08-11 1996-08-06 Use of prostane derivatives and the combination thereof with antibiotics in the treatment of bacterial infections

Publications (2)

Publication Number Publication Date
SK15698A3 SK15698A3 (en) 1998-06-03
SK284195B6 true SK284195B6 (sk) 2004-10-05

Family

ID=7770106

Family Applications (1)

Application Number Title Priority Date Filing Date
SK156-98A SK284195B6 (sk) 1995-08-11 1996-08-06 Použitie prostanových derivátov a kombinácia týchto látok s antibiotikami na liečenie bakteriálnych infekcií

Country Status (25)

Country Link
US (1) US6040336A (es)
EP (1) EP0852497B1 (es)
JP (1) JPH11510809A (es)
CN (1) CN1080562C (es)
AT (1) ATE219368T1 (es)
AU (1) AU702706B2 (es)
BR (1) BR9609932A (es)
CA (1) CA2228036A1 (es)
CZ (1) CZ291534B6 (es)
DE (2) DE19530884C2 (es)
DK (1) DK0852497T3 (es)
ES (1) ES2181907T3 (es)
HK (1) HK1015707A1 (es)
HU (1) HUP9802450A3 (es)
IL (1) IL122826A (es)
MX (1) MX9801118A (es)
NO (1) NO316424B1 (es)
PL (1) PL184840B1 (es)
PT (1) PT852497E (es)
RU (1) RU2201232C2 (es)
SK (1) SK284195B6 (es)
TR (1) TR199800128T1 (es)
UA (1) UA54397C2 (es)
WO (1) WO1997006806A1 (es)
ZA (1) ZA966775B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6663967B1 (en) * 2000-11-17 2003-12-16 Bryant Rubber Corporation Moldable silicone elastomers having selective primerless adhesion
EP2269611B1 (en) 2006-11-16 2016-03-23 Gemmus Pharma Inc. EP2 and EP4 agonists as agents for the treatment of influenza A viral infection
EP2803365A1 (en) 2013-05-14 2014-11-19 Commissariat A L'energie Atomique Et Aux Energies Alternatives Use of clonazepam in combination with antibiotic in the treatment of bacterially induced meningitis
US12042503B2 (en) 2020-02-12 2024-07-23 Cytoagents, Inc. Compositions and methods for treating coronavirus infections

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US447802A (en) * 1891-03-10 Irvest williams
DE2845770A1 (de) * 1978-10-19 1980-04-30 Schering Ag Neue prostacyclin-derivate und verfahren zu ihrer herstellung
JPS58124778A (ja) * 1982-01-20 1983-07-25 Toray Ind Inc ５，６，７−トリノル−４，８−インタ−ｍ−フエニレンＰＧＩ↓２誘導体
US4665088A (en) * 1984-11-14 1987-05-12 The Research Foundation Of State University Of New York (E-Z)-4,5,9-trithiadodeca-1,6,11-triene 9-oxides
EP0234481A1 (en) * 1986-02-18 1987-09-02 Syntex (U.S.A.) Inc. Anti-infective injectable formulations
DE4104607A1 (de) * 1991-02-12 1992-08-13 Schering Ag Prostacyclin- und carbacyclinderivate als mittel zur behandlung von fiebrigen erkrankungen
DK0758233T3 (da) * 1994-04-21 2004-03-22 Schering Ag PDE IV-inhibitorer til behandling af multipel sklerose

Also Published As

Publication number Publication date
ES2181907T3 (es) 2003-03-01
JPH11510809A (ja) 1999-09-21
CZ291534B6 (cs) 2003-03-12
BR9609932A (pt) 1999-06-08
IL122826A0 (en) 1998-08-16
PL184840B1 (pl) 2002-12-31
CN1080562C (zh) 2002-03-13
PL324884A1 (en) 1998-06-22
DE69621939D1 (de) 2002-07-25
NO980568D0 (no) 1998-02-10
US6040336A (en) 2000-03-21
IL122826A (en) 2001-11-25
EP0852497A1 (en) 1998-07-15
SK15698A3 (en) 1998-06-03
DE69621939T2 (de) 2003-01-09
EP0852497B1 (en) 2002-06-19
HUP9802450A3 (en) 1999-08-30
CN1192684A (zh) 1998-09-09
CZ41498A3 (cs) 1998-09-16
NO316424B1 (no) 2004-01-26
AU702706B2 (en) 1999-03-04
NO980568L (no) 1998-02-10
HUP9802450A2 (hu) 1999-02-01
HK1015707A1 (en) 1999-10-22
DE19530884C2 (de) 1997-07-31
WO1997006806A1 (en) 1997-02-27
AU6871196A (en) 1997-03-12
DE19530884A1 (de) 1997-02-20
ATE219368T1 (de) 2002-07-15
TR199800128T1 (xx) 1998-04-21
PT852497E (pt) 2002-10-31
UA54397C2 (uk) 2003-03-17
MX9801118A (es) 1998-10-31
ZA966775B (en) 1997-02-19
DK0852497T3 (da) 2002-08-12
RU2201232C2 (ru) 2003-03-27
CA2228036A1 (en) 1997-02-27

Similar Documents

Publication Publication Date Title
US5688819A (en) Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US8017655B2 (en) Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US4499085A (en) Method of anoxia treatment using prostaglandin analogues
EP0366279B1 (en) Ocular hypotensive agents
KR920007570B1 (ko) 체온 상승제
SK284195B6 (sk) Použitie prostanových derivátov a kombinácia týchto látok s antibiotikami na liečenie bakteriálnych infekcií
EP0458589B1 (en) Treatment of ocular hypertension with an ocular synergistic combination
EP0458590B1 (en) Treatment of ocular hypertention with a synergistic combination
US5405846A (en) Treatment of ocular hypertension with a synergistic combination
DE3740838A1 (de) Cyclodextrinclathrate von 5-cyano-prostacyclinderivaten und ihre verwendung als arzneimittel
CA2030344C (en) Treatment of pulmonary dysfunction with 15-keto-prostaglandin compounds
CA2042936C (en) Treatment of ocular hypertension with a synergistic combination for ophthalmic use
CA2061907C (en) Treatment of ocular hypertension with a synergistic combination
EP0737185B1 (en) 7-[carboxyalkyl or alkenyl]-6-[alkyl or alkenyl] 3-oxo-2,4-dioxobicyclo-[3.2.1] octane and derivatives thereof
US6127413A (en) Ocular depressor
US5175189A (en) Treatment of ocular hypertension with a synergistic combination for ophthalmic use
JPH02160721A (ja) プロスタグランジン類似化合物を有効成分として含有する膵炎治療剤